Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial

por Grebely, Jason, Read, Phillip, Cunningham, Evan B., Weltman, Martin, Matthews, Gail V., Dunlop, Adrian, Montebello, Mark, Martinello, Marianne, Gilliver, Rosie, Marks, Philippa, Applegate, Tanya L., Dore, Gregory J.
Publicado 2020

Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis

por Shih, Sophy T.F., Cheng, Qinglu, Carson, Joanne, Valerio, Heather, Sheehan, Yumi, Gray, Richard T., Cunningham, Evan B., Kwon, Jisoo A., Lloyd, Andrew R., Dore, Gregory J., Wiseman, Virginia, Grebely, Jason
Publicado 2023

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

por Degenhardt, Louisa, Peacock, Amy, Colledge, Samantha, Leung, Janni, Grebely, Jason, Vickerman, Peter, Stone, Jack, Cunningham, Evan B, Trickey, Adam, Dumchev, Kostyantyn, Lynskey, Michael, Griffiths, Paul, Mattick, Richard P, Hickman, Matthew, Larney, Sarah
Publicado 2017

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study

por Conway, Anna, Read, Phillip, Gilliver, Rosie, McNaughton, Tony, Valerio, Heather, Cunningham, Evan B., Henderson, Charles, Hadlow, Brett, Molloy, Katrina, Doab, Anna, Tillakeratne, Shane, Pepolim, Lucy, Harrod, Mary Ellen, Dore, Gregory J., Grebely, Jason
Publicado 2022

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

por Larney, Sarah, Peacock, Amy, Leung, Janni, Colledge, Samantha, Hickman, Matthew, Vickerman, Peter, Grebely, Jason, Dumchev, Kostyantyn V, Griffiths, Paul, Hines, Lindsey, Cunningham, Evan B, Mattick, Richard P, Lynskey, Michael, Marsden, John, Strang, John, Degenhardt, Louisa
Publicado 2017

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

por Hines, Lindsey A, Trickey, Adam, Leung, Janni, Larney, Sarah, Peacock, Amy, Degenhardt, Louisa, Colledge, Samantha, Hickman, Matthew, Grebely, Jason, Cunningham, Evan B, Stone, Jack, Dumchev, Kostyantyn, Griffiths, Paul, Vickerman, Peter, Mattick, Richard P, Lynskey, Michael
Publicado 2019

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

por Cunningham, Evan B., Hajarizadeh, Behzad, Dalgard, Olav, Amin, Janaki, Hellard, Margaret, Foster, Graham R, Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L, Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Thurnheer, Maria Christine, Dore, Gregory J, Grebely, Jason
Publicado 2017

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

por Howe, Anita Y.M., Rodrigo, Chaturaka, Cunningham, Evan B., Douglas, Mark W., Dietz, Julia, Grebely, Jason, Popping, Stephanie, Sfalcin, Javier Alejandro, Parczewski, Milosz, Sarrazin, Christoph, de Salazar, Adolfo, Fuentes, Ana, Sayan, Murat, Quer, Josep, Kjellin, Midori, Kileng, Hege, Mor, Orna, Lennerstrand, Johan, Fourati, Slim, Di Maio, Velia Chiara, Chulanov, Vladimir, Pawlotsky, Jean-Michel, Harrigan, P. Richard, Ceccherini-Silberstein, Francesca, Garcia, Federico
Publicado 2022